Secukinumab is e¿ective in the treatment of recalcitrant palmoplantar psoriasis and palmoplantar pustular psoriasis in a daily practice setting Academic Article 2022 uri icon

authors

  • Reolid A
  • Romero Maté A
  • Vidal D
  • Coto-Segura P
  • Herrera Acosta E
  • Riera Monroig J
  • Salgado L
  • Llamas-Velasco M
  • Dauden E
  • Arnesto S
  • Sahuquillo Torralba A
  • Torres T
  • Feltes R
  • Vilarrasa E
  • BELINCHON ROMERO, ISABEL
  • Cueva P
  • Rodríguez L

publication date

  • 2022